Tag: Quality Documents & SOPs

What a change control record proves, and what an inspector increasingly wants to see A health authority inspector, midway through

Explore how modular content and structured component workflows empower pharma companies to optimise reuse, shorten reviews and manage global/local content with agility.

Explore 10 essential questions to evaluate AI-powered Structured Content Authoring (SCA) vendors—focused on reuse, metadata, audit readiness, systems and long-term strategy.

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution, thanks to the rapid integration of artificial intelligence (AI). We’re experiencing a transformation that will likely redefine every aspect of the medical field, from research and drug development to patient care — and beyond.

Are you wondering where to start with your change management strategy as you integrate Docuvera’s structured component authoring (SCA) into your enterprise? Adding new solutions to your tech stack is not just a “change of software” but an opportunity for transformation. For life sciences organizations, letting go of disconnected systems and centralizing content and workflow is a game changer. 

Artificial intelligence (AI). It’s everywhere, and it’s changing the world as we know it. From chatbots to self-driving cars, AI is here to make our lives easier AND take our jobs. Right? Well…not exactly, our jobs are safe for now.

Around the globe, artificial intelligence (AI) is all the buzz, including international healthcare events like DIA Europe and DIA Global. With the potential to revolutionize healthcare, accelerate drug discovery, and enhance patient outcomes, AI has sparked immense excitement in the life sciences — assuming it can find its ideal application.

The drug documentation lifecycle is long and involves many people along the way. From in-depth review processes to challenges in auditing and tracking content, Life Sciences organizations that are still using publishing programs like Microsoft Word are likely spending a lot of resources to build document processes based on 1980s technology.

In Pharma, one form of technology that offers great promise is a structured component authoring (SCA) platform. When Life Sciences organizations choose to roll out new tools of any type, hopes are typically high; adoption needs to go smoothly all the way from implementation to individual use. You want resources to support functionality. And you want a solution that saves your organization time and money on whatever problem you thought the product might solve.

To keep up with the times or rather, persevere to the future, Life Sciences organizations need to match the pace of progress. Ironically, this industry has been one of the slowest to adopt technology to help optimize the processes and workflows that could essentially change the world.

Are you still using a program like Microsoft Word for your medical authoring and documentation? What if we told you that AI and structured content  can give authors advantages like flexibility, improved compliance capabilities, better data integration and more?

When making a decision on a technology vendor, there are many considerations. Will it alleviate a significant problem? What does the onboarding process look like? Is there a support system for after the installation?

Technology can be a game-changer that streamlines complex processes, enhances productivity and increases efficiency. For Life Sciences organizations, a structured component authoring (SCA) platform can help transform the medical authoring and documentation process — as long as you can get everyone on board. With this in mind, we’re sharing our top three tips for a successful SCA implementation.